Clinical Trial Update: Ketamine for Relapse Prevention in Recurrent Depressive Disorder [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating ketamine for relapse prevention in recurrent depressive disorder has been terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder
• Major Depressive Disorder
• Relapse

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: St Patrick's Hospital, Ireland | Conditions: Depression, Relapse | Phase 1 | Status: TERMINATED | Results posted: 2020-01-13